Awarded
NHS National Framework Agreement for the Supply of Generic Pharmaceuticals — Interim 1 2020
Descriptions
NHS national framework agreement for the supply of generic pharmaceuticals — Interim 1 2020.Offer reference number: CM/PHG/20/5589Period of framework agreement: the total maximum duration of the framework agreement to be no more than 24 months (12 months plus options to extend (at the authority's sole discretion) for up to a further 12 months).Potential periods of call-offs under the framework agreementHospital Only Products:DLS/DNE/DNW 1 August 2020 to 31 July 2021 (12 months),DLN/DCE/DSW 1 August 2020 to 31 July 2021 (12 months).Products on the framework include (but are not limited to):— Darunavir— Disodium Pamidronate— Doxorubicin— Epirubicin— Ethambutol— Etoposide— Glycopyrronium Bromide— Ibuprofen— Irinotecan— Lopinavir/Ritonavir— Milrinone— Posaconazole— Ritonavir— Salbutamol— Tramadol— Vancomycin.Details of presentation sizes and volumes are within the tender document set.
Timeline
Published Date :
Deadline :
Tender Awarded :
Awarded date :
Contract Start :
Contract End :
Tender Regions
Wales
CPV Codes
33690000 - Various medicinal products
33600000 - Pharmaceutical products
Keywords
medicinal drugs
prescription medicines
generic pharmaceuticals
active pharmaceutical ingredients
pharmaceutical compounds
diverse pharmaceuticals
general drug products
healthcare medications
assorted therapeutic agents
medical product range
Tender Lot Details
2 Tender Lots
Workflows
Status :
Assign to :
Tender Progress :
Details
Notice Type :
Tender Identifier :
TenderBase ID :
Low Value :
High Value :
Region :
Attachments :
Buyer Information
Address :
Website :
Procurement Contact
Name :
Designation :
Phone :
Email :
Possible Competitors
1 Possible Competitors
